Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -198.70K | -189.10K | -172.00K | -193.30K | -205.20K |
| Total Depreciation and Amortization | 6.60K | 12.40K | 15.70K | 15.10K | -17.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.20K | 4.50K | 8.70K | 47.90K | 41.00K |
| Change in Net Operating Assets | 110.00K | 25.00K | -367.20K | 882.50K | 283.30K |
| Cash from Operations | -81.00K | -147.30K | -514.80K | 752.20K | 101.40K |
| Capital Expenditure | -2.00K | -31.30K | -18.20K | -1.00K | -1.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -31.30K | -18.20K | -1.00K | -1.40K |
| Total Debt Issued | 87.50K | 177.30K | 356.40K | -111.90K | -84.40K |
| Total Debt Repaid | -3.60K | -1.10K | -20.70K | -459.20K | -11.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -800.00 | -700.00 | -600.00 | -700.00 | -900.00 |
| Cash from Financing | 83.10K | 175.50K | 335.10K | -571.80K | -96.30K |
| Foreign Exchange rate Adjustments | 800.00 | 600.00 | 4.70K | 7.80K | 200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.00K | -2.50K | -193.20K | 187.20K | 3.80K |
